找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Interventional and Endovascular Therapy of the Nervous System; A Practical Guide Pearse Morris Book 2002 Springer Science+Business Media Ne

[復(fù)制鏈接]
樓主: 照相機
31#
發(fā)表于 2025-3-26 23:15:51 | 只看該作者
32#
發(fā)表于 2025-3-27 03:24:35 | 只看該作者
Thrombolysis and Treatment of Acute Stroke,rsible brain injury probably begins about 5 minutes after onset of complete global ischemia, which does not allow much scope for completely effective therapy.. However, degrees of ischemia and vascular occlusion are variable in symptomatic patients, which means that some stroke patients can be helpe
33#
發(fā)表于 2025-3-27 06:51:19 | 只看該作者
Venous Thrombotic Disease, protein C, protein S, and factor V Leiden, or an increase in anticardiolipin A antibodies may be identified in patients with this disorder, but a precise pathogenesis may not be identifiable in 25% to 35% of patients.. The disease is frequently overlooked clinically and on CT imaging, in part due t
34#
發(fā)表于 2025-3-27 09:43:23 | 只看該作者
35#
發(fā)表于 2025-3-27 16:35:11 | 只看該作者
Extracranial Carotid and Vertebral Angioplasty and Stenting,making this also the first report of carotid PTA with distal protection. In 1980 again Sundt et al. reported the first successful transluminal angioplasties of basilar artery stenoses through intraoperative exposures..
36#
發(fā)表于 2025-3-27 21:42:59 | 只看該作者
Intracranial Angioplasty and Stenting,s aspirin in the treatment of intracranial stenosis indicates a slightly greater efficacy from warfarin in symptomatic patients. Rates of major vascular events of 8.4% (stroke 3.6%) with warfarin and 18.1% (stroke 10.4%) per year with aspirin were seen.? Evidence supporting a slightly greater effica
37#
發(fā)表于 2025-3-28 00:38:24 | 只看該作者
38#
發(fā)表于 2025-3-28 05:58:45 | 只看該作者
39#
發(fā)表于 2025-3-28 08:51:37 | 只看該作者
40#
發(fā)表于 2025-3-28 11:39:38 | 只看該作者
Pearse Morris MDder Wahrheit über die Gewalt. Die Folgen mussten das Ansehen der kommunistischen Ideologie erschüttern. Es hatte sich herausgestellt, dass zwischen der angeblic978-94-010-3691-7978-94-010-3690-0Series ISSN 0561-2551
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 13:13
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
井研县| 石家庄市| 海晏县| 光泽县| 蒙阴县| 大同市| 日照市| 会东县| 南召县| 土默特右旗| 柘城县| 金川县| 涪陵区| 镇雄县| 阳曲县| 岫岩| 长宁区| 博罗县| 千阳县| 高陵县| 正镶白旗| 资中县| 阿城市| 平武县| 中阳县| 望谟县| 游戏| 仁化县| 积石山| 临清市| 湖南省| 于田县| 秦皇岛市| 潞城市| 唐海县| 托克托县| 沾化县| 桦川县| 天镇县| 阿坝县| 新野县|